Advance Auto Parts Reports Q4 & FY25 Turnaround, Issues Positive FY26 Guidance
summarizeSummary
Advance Auto Parts reported a return to positive comparable sales growth for Q4 and full year 2025, along with significant operating margin expansion, and provided optimistic guidance for 2026.
check_boxKey Events
-
Return to Positive Comparable Sales Growth
The company reported Q4 2025 comparable sales growth of 1.1% and full-year 2025 comparable sales growth of 0.8%, marking a return to positive growth after three consecutive years of negative results.
-
Significant Operating Margin Expansion
Full-year 2025 adjusted operating margin expanded by over 200 basis points to 2.5%, reflecting improved operational efficiency.
-
Improved Profitability
Q4 2025 adjusted diluted EPS was $0.86, a significant improvement from a loss of $(1.18) in the prior year quarter. Full-year 2025 adjusted diluted EPS was $2.26, up from a loss of $(0.29) in the prior year.
-
Positive 2026 Guidance Issued
For full-year 2026, the company projects comparable sales growth of 1.0% to 2.0%, adjusted operating income margin of 3.8% to 4.5%, and adjusted diluted EPS in the range of $2.40 to $3.10.
auto_awesomeAnalysis
Advance Auto Parts has demonstrated a significant turnaround, returning to positive comparable sales growth for both the fourth quarter and full year 2025 after three years of negative results. The company also achieved substantial adjusted operating margin expansion and a shift to positive adjusted diluted EPS. The forward guidance for 2026 reinforces this positive trajectory, projecting accelerated comparable sales growth, further margin expansion, and a notable improvement in free cash flow from a significant outflow in 2025 to a projected positive inflow. This indicates successful execution of its strategic plan and provides a more optimistic outlook for the company's financial health and operational efficiency.
At the time of this filing, AAP was trading at $58.00 on NYSE in the Trade & Services sector, with a market capitalization of approximately $3.5B. The 52-week trading range was $28.89 to $70.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.